GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xlife Sciences AG (CHIX:XLSz) » Definitions » YoY EBITDA Growth

Xlife Sciences AG (CHIX:XLSZ) YoY EBITDA Growth : 55.97% (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Xlife Sciences AG YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Xlife Sciences AG's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was 55.97%.

Xlife Sciences AG's EBITDA per Share for the six months ended in Dec. 2024 was CHF5.03.

Xlife Sciences AG YoY EBITDA Growth Historical Data

The historical data trend for Xlife Sciences AG's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xlife Sciences AG YoY EBITDA Growth Chart

Xlife Sciences AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY EBITDA Growth
Get a 7-Day Free Trial 721.27 139.31 -67.08 1.12 90.77

Xlife Sciences AG Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -57.24 31.79 -4.58 227.49 55.97

Xlife Sciences AG YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Xlife Sciences AG's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (A: Dec. 2024 )
=(EBITDA per Share (A: Dec. 2024 )-EBITDA per Share (A: Dec. 2023 ))/ | EBITDA per Share (A: Dec. 2023 ) |
=(5.517-2.892)/ | 2.892 |
=90.77 %

Xlife Sciences AG's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (Q: Dec. 2024 )
=(EBITDA per Share (Q: Dec. 2024 )-EBITDA per Share (Q: Dec. 2023 )) / | EBITDA per Share (Q: Dec. 2023 )) |
=(5.033-3.227)/ | 3.227 |
=55.97 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xlife Sciences AG YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Xlife Sciences AG's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Xlife Sciences AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xlife Sciences AG (CHIX:XLSz) » Definitions » YoY EBITDA Growth
Comparable Companies
XSWX:NWRN XSWX:MOLN XSWX:SANN XSWX:BIOV XSWX:RLF XSWX:IDIA XSWX:EVE XSWX:ADXN XSWX:BSLN VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270 SMMT
Traded in Other Exchanges
XLS:Switzerland
Address
Talacker 35, Zurich, CHE, 8001
Website
https://www.xlifesciences.ch
Xlife Sciences AG is a Swiss incubator and accelerator company focused on the value development and commercialization of research projects from universities and other life science research institutions, to provide solutions for high unmet medical needs. It holds majority or minority interests in project companies that are engaged in areas of the company's reportable segments which include Technology platforms, Medical Technology, Biotechnology/Therapeutics, and Artificial intelligence/digital medicine.

Xlife Sciences AG Headlines

No Headlines